Latest filing published 28 Mar 2024 for InnoCan Pharma Corporation.
No signal scores available.
Ron Mayron appears in our data through filings on InnoCan Pharma Corporation shares, published by SEDI. Over a trading history stretching from 13 September 2019 to 25 March 2024, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 28 March 2024 with a transaction in InnoCan Pharma Corporation. Between a trade and the moment it shows up on SEDI, the median delay is 9 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations